Abstract
The induction of growth inhibition and differentiation of a glioma cell line by transfection of trk A cDNA was examined, and production of endogenous nerve growth factor (NGF) also was studied in these cells. When human trk A cDNA was transfected into a human glioma cell line, U-251MG, which lacks expression of both endogenous trk A and low-affinity NGF receptor, the transfectant expressed the exogenous trk A mRNA and a functional high-affinity NGF receptor. Transfection of trk A cDNA caused a partial induction of cell differentiation, G1 arrest, growth inhibition, tyrosine phosphorylation of the trk A proto-oncogene product, and activation of MAP kinase. Exogenous NGF treatment induced further terminal differentiation and growth inhibition. In summary, our data suggest that endogenous NGF secreted by glioma cells has an important role in the induction of glioma-cell differentiation occuring with transfer of exogenous trk A cDNA.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schoenberg BS: The epidemiology of central nervous system tumors. In: Walker MD (ed). Oncology of the Nervous System, Boston, Martinus Nijhoff, 1983 pp 1–30
Mahaley MS, Mettlin C, Natarajan N, Laws ER, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826–836, 1989
Huber BE: Gene therapy strategies for treating neoplastic disease. Ann NY Acad Sci 716: 6–11, 1992
Levi-Montalcini R: The nerve growth factor 35 years later. Science 237: 1154–1162, 1987
Yankner BA, Shooter EM: The biology and mechanism of action of nerve growth factor. Annu Rev Biochem 51: 845–868, 1982
Johnson D, Lanahan A, Buck CR, Sehgel A, Morgan C, Mercer E, Bothwell NM, Chao M: Expression and structure of the human NGF receptor. Cell 47: 545–554, 1986
Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM: Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325: 593–597, 1987
Kaplan D, Hempsteadt B, Martin-Zanca D, Chao M, Parada L: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 252: 554–558, 1991
Klein R, Jing S, Nanduri V, O'Rouke E, Barbacid M: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65: 189–197, 1991
Barbacid M: Nerve growth factor: A tale of two receptors. Oncogene 8: 2033–2042, 1993
Hempstead B, Schleifer LS, Chao M: Expression of functional nerve growth factor receptors after gene transfer. Science 243: 373–375, 1989
Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC: Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Ins 85: 377–385, 1993
Matsushima H, Bogenmann E: Expression of trk A cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol Cell Biol 13: 7447–7456, 1993
Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM: Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52: 1364–1368, 1992
Poluha W, Poluha DK, Ross AH: Trk A neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 10: 185–189, 1995
Kokunai T, Kawamura A, Tamaki N: Functional analysis of trk proto-oncogene product in medulloblastoma cells. Neurol Med Chir 36: 796–804, 1996
Martin-Zanca D, Hughes SH, Barbacid MA: Human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319: 743–748, 1986
Maniatis T, Fritsch EF, Sambrook J: Molecular cloning. Alaboratory manual. Cold Spring Harbor Laboratory, New York, 1982
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Sutter A, Riopelle RJ, Hanis-Warrick RM, Shooter EM: Nerve growth factor receptors. J Biol Chem 254: 5972–5982, 1979
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354, 1979
Vale RD, Shooter EM: Assaying binding of nerve growth factor to cell surface receptors. Methods Enzymol 109: 21–39, 1985
Stewart N, Hicks GC, Paraskevas F, Mowat M: Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109–115, 1995
Barnett J, Baecker P, Routledge-Ward C, Bursztyn-Pettegrew H, Chow J, Nguyen B, Bach C, Chan H, Tuszynski MH, Yoshida K, Rubalcava R, Gage FH: Human ß nerve growth factor obtained from a baculovirus expression system has potent in vitro and in vivo neurotrophic activity. Exp Neurol 110: 11–24, 1990
Mocchetti I, De Bernardi MA, Szekely AM, Alho H, Brooker G, Costa E: Regulation of nerve growth factor biosynthesis by ß-adrenergic receptor activation in astrocytoma cells: A potential role of c-Fos protein. Proc Natl Acad Sci USA 86: 3891–3895, 1989
Bongeam-Rudloff E, NistÈr M, Betsholtz C, Wang J-L, Stenman G, Huebner K, Croce CM, Westermark B: Human glial fibrillary acidic protein: Complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes. Cancer Res 51: 1553–1560, 1991
Weinstein DE, Shelanski ML, Liem RHH: Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112: 1205–1213, 1991
Chen P-L, Scully P, Shew J-Y, Wang JYL, Lee W-H: Phosphorylation of the retinoblastoma gene product is modulating during the cell cycle and cellular differentiation. Cell 58: 1193–1198, 1989
Kokunai T, Kawamura A, Tamaki N: Induction of differentiation by wild-type p53 gene in a human glioma cell line. J Neuro-Oncol 32: 125–133, 1996
Rudkin BB, Lazarovici P, Levi B-Z, Abe Y, Fujita K, Guroff G: Cell cycle-specific action of nerve growth factor in PC12 cells: Differentiation without proliferation. EMBOJ 8: 3319–3325, 1989
Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: A family of proteinserine/ threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663–675, 1991
Halegoua S, Armstrong RC, Kremer NE: Dissecting the mode of action of a neuronal growth factor. Curr Top Microbiol Immunol 165: 119–170, 1991
Kaplan DR, Martin-Zanca D, Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350: 158–160, 1991
Morgan JI, Curran T: Stimulus-transcription coupling in the nervous system: Involvement of the inducible protooncogenes fos and jun. Annu Rev Neurosci 14: 421–451, 1991
Greenberg ME, Greene LA, Ziff EB: Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC 12 cells. J Biol Chem 260: 14101–14110, 1985
Miyasaka T, Sternberg DW, Miyasaka J, Sherline P: Nerve growth factor stimulates protein tyrosine phosphorylation in PC-12 pheochromocytoma cells. Proc Natl Acad Sci USA 88: 2653–2657, 1991
Zafra F, Lindholm D, CastrÈn E, Hartikka J, Thonen H: Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 12: 4793–4799, 1992
Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Näher-NoÈ M, Thoenen H: Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: Comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 2: 69–76, 1990
Yamakuni T, Ozawa F, Hishinuma F, Kuwano R, Takahashi Y, Amano Y: Expression of ß-nerve growth factor mRNA in rat glioma cells and astrocytes from rat brain. FEBS Lett 223: 117–121, 1987
Norrgren G, Ebendal M, Belew M, Jacobson C-O, Porath J: Release of nerve growth factor by human glial cells in culture. Exp Cell Res 130: 31–39, 1980
Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K: Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Comm 136: 57–63, 1986
Edwards RH, Selby MJ, Mobley WC, Weinrich SL, Hruby DE, Rutter WJ: Processing and secretion of nerve growth factor: Expression in mammalian cells with a vaccinia virus vector. Mol Cell Biol 8: 2456–2464, 1988
Bogenmann E, Torres M, Matsushima H: Constitutive N-myc gene expression inhibits trk A mediated neuronal differentiation. Oncogene 10: 1915–1925, 1995
Zhou J, Holtzman DM, Weiner RI, Mobley WC: Expression of Trk A confers neuron like responsiveness to nerve growth factor on an immortalized hypothalamic cell line. Proc Natl Acad Sci USA 91: 3824–3828, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kokunai, T., Iguchi, H. & Tamaki, N. Differentiation and Growth Inhibition of Glioma Cells Induced by Transfer of trk A Proto-oncogene. J Neurooncol 42, 23–34 (1999). https://doi.org/10.1023/A:1006133026675
Issue Date:
DOI: https://doi.org/10.1023/A:1006133026675